MedPath

The effect of cognitive hypnotherapy in preventing the relapse of opium use in men treated with methadone

Phase 2
Conditions
Men treated with methadone.
Registration Number
IRCT20170108031818N4
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
38
Inclusion Criteria

All opium consuming men who have completed a one-month detoxification course and are undergoing maintenance treatment with methadone and have a file in the addiction treatment center affiliated to 5 Azar Hospital in Gorgan.
Age 18–55 years
Not using other drugs and narcotic drugs for a month before
At least elementary education
No history of stimulant drug use

Exclusion Criteria

Absence of more than 2 sessions of cognitive hypnotherapy
Non-cooperation of the patient to monitor the urine test before intervention, after cognitive hypnotherapy and 3 months and 6 months after treatment sessions.
Serious medical illness or major psychiatric disorder (depression, psychosis, etc.) based on a clinical interview by a psychiatric assistant

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Opium relapse. Timepoint: 3 months later and 6 months later. Method of measurement: The morphine urine test is a multi-drug test, and if morphine is positive in this test, it is considered as a relapse of drug abuse.
Secondary Outcome Measures
NameTimeMethod
Impulsiveness. Timepoint: 3 months later and 6 months later. Method of measurement: Ernst Barratt Impulsivity Questionnaire.;Reduced drug cravings. Timepoint: 3 months later and 6 months later. Method of measurement: with the Abbreviated Substance Craving Scale.
© Copyright 2025. All Rights Reserved by MedPath